Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 4/20 | 0.42 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.42 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.42 |
| ▸ | PRMT5 | O14744 | 5/20 | 0.41 |
| ▸ | WDR77 | Q9BQA1 | 5/20 | 0.41 |
| ▸ | POLRMT | O00411 | 1/20 | 0.39 |
| ▸ | P2RX1 | P51575 | 3/20 | 0.38 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.38 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.38 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.37 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.36 |
| ▸ | ADK | P55263 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21078516 | 1.00 | P2RY1 (0.42) | P2RY1P2RY2P2RY11PRMT5WDR77 | |
| SCHEMBL19397146 | 0.91 | P2RY2 (0.41) | P2RY1P2RY2P2RY11PRMT5WDR77 | |
| SCHEMBL31228172 | 0.89 | PRMT5 (0.45) | P2RY1P2RY2P2RY11PRMT5WDR77 | |
| SCHEMBL19986635 | 0.88 | PRMT5 (0.40) | P2RY1P2RY2P2RY11PRMT5WDR77 | |
| SCHEMBL21078488 | 0.86 | P2RY1 (0.56) | P2RY1P2RY2P2RY11P2RX1P2RX3 | |
| SCHEMBL21078481 | 0.85 | P2RY1 (0.42) | P2RY1P2RY2P2RY11POLRMTP2RX1 | |
| SCHEMBL21078486 | 0.85 | P2RY2 (0.42) | P2RY1P2RY2P2RY11PRMT5WDR77 | |
| SCHEMBL31228238 | 0.85 | P2RY1 (0.42) | P2RY1P2RY2P2RY11POLRMTP2RX1 | |
| SCHEMBL21078478 | 0.84 | P2RY1 (0.41) | P2RY1P2RY2P2RY11POLRMTP2RX1 | |
| SCHEMBL31228193 | 0.84 | P2RY1 (0.41) | P2RY1P2RY2P2RY11POLRMTP2RX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705313-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | The Scripps Research Institute (US) | 2026-03-11 | — | — | EP | claimed |
| WO-2024227159-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-31 | — | — | WO | claimed |
| EP-4705313-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | The Scripps Research Institute (US) | 2026-03-11 | — | — | EP | disclosed |
| WO-2024227159-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-31 | — | — | WO | disclosed |